CRVO
Price
$10.25
Change
-$0.31 (-2.94%)
Updated
May 2 closing price
Capitalization
89.2M
NKTR
Price
$0.75
Change
-$0.03 (-3.85%)
Updated
May 2 closing price
Capitalization
139.95M
5 days until earnings call
Ad is loading...

CRVO vs NKTR

Header iconCRVO vs NKTR Comparison
Open Charts CRVO vs NKTRBanner chart's image
CervoMed
Price$10.25
Change-$0.31 (-2.94%)
Volume$788.31K
Capitalization89.2M
Nektar Therapeutics
Price$0.75
Change-$0.03 (-3.85%)
Volume$1.4M
Capitalization139.95M
CRVO vs NKTR Comparison Chart
Loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRVO vs. NKTR commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVO is a Hold and NKTR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (CRVO: $10.25 vs. NKTR: $0.75)
Brand notoriety: CRVO: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVO: 13% vs. NKTR: 67%
Market capitalization -- CRVO: $89.2M vs. NKTR: $139.95M
CRVO [@Biotechnology] is valued at $89.2M. NKTR’s [@Biotechnology] market capitalization is $139.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVO’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • CRVO’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, CRVO is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVO’s TA Score shows that 3 TA indicator(s) are bullish while NKTR’s TA Score has 6 bullish TA indicator(s).

  • CRVO’s TA Score: 3 bullish, 4 bearish.
  • NKTR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than CRVO.

Price Growth

CRVO (@Biotechnology) experienced а +18.63% price change this week, while NKTR (@Biotechnology) price change was -2.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

CRVO is expected to report earnings on Mar 17, 2025.

NKTR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($140M) has a higher market cap than CRVO($89.2M). CRVO YTD gains are higher at: 338.034 vs. NKTR (-19.140). CRVO has higher annual earnings (EBITDA): -7.83M vs. NKTR (-137.77M). NKTR has more cash in the bank: 244M vs. CRVO (46.7M). CRVO has less debt than NKTR: CRVO (0) vs NKTR (108M). NKTR has higher revenues than CRVO: NKTR (93.1M) vs CRVO (0).
CRVONKTRCRVO / NKTR
Capitalization89.2M140M64%
EBITDA-7.83M-137.77M6%
Gain YTD338.034-19.140-1,766%
P/E Ratio4.73N/A-
Revenue093.1M-
Total Cash46.7M244M19%
Total Debt0108M-
FUNDAMENTALS RATINGS
CRVO vs NKTR: Fundamental Ratings
CRVO
NKTR
OUTLOOK RATING
1..100
7520
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
3458
P/E GROWTH RATING
1..100
6381
SEASONALITY SCORE
1..100
44n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (49) in the Biotechnology industry is in the same range as NKTR (59). This means that CRVO’s stock grew similarly to NKTR’s over the last 12 months.

CRVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NKTR (100). This means that CRVO’s stock grew similarly to NKTR’s over the last 12 months.

CRVO's SMR Rating (94) in the Biotechnology industry is in the same range as NKTR (96). This means that CRVO’s stock grew similarly to NKTR’s over the last 12 months.

CRVO's Price Growth Rating (34) in the Biotechnology industry is in the same range as NKTR (58). This means that CRVO’s stock grew similarly to NKTR’s over the last 12 months.

CRVO's P/E Growth Rating (63) in the Biotechnology industry is in the same range as NKTR (81). This means that CRVO’s stock grew similarly to NKTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVONKTR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOFPY11.460.34
+3.06%
Greek Organisation of Football Prognostics SA
ANCTF51.731.33
+2.64%
Alimentation Couche-Tard Inc.
KUBTY58.110.94
+1.64%
Kubota Corp.
ALYAF1.310.02
+1.55%
Alithya Group Inc.
BMXI0.03N/A
-3.28%
Brookmount Explorations, Inc.

CRVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVO has been loosely correlated with TCRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVO jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
-2.94%
TCRX - CRVO
34%
Loosely correlated
+3.23%
LVTX - CRVO
28%
Poorly correlated
+3.23%
VKTX - CRVO
27%
Poorly correlated
+2.60%
NKTR - CRVO
27%
Poorly correlated
-3.60%
AVXL - CRVO
27%
Poorly correlated
+0.54%
More